105 related articles for article (PubMed ID: 15013280)
1. Augmentation of in-stent clot dissolution by low frequency ultrasound combined with aspirin and heparin. An ex-vivo canine shunt study.
Neuman Y; Rukshin V; Tsang V; Atar S; Miyamoto T; Luo H; Kobal S; Thompson T; Birnbaum Y; Horzewski M; Siegel RJ; Kaul S
Thromb Res; 2003; 112(1-2):99-104. PubMed ID: 15013280
[TBL] [Abstract][Full Text] [Related]
2. Iliac venous stenting: antithrombotic efficacy of PD0348292, an oral direct Factor Xa inhibitor, compared with antiplatelet agents in pigs.
McBane RD; Leadley RJ; Baxi SM; Karnicki K; Wysokinski W
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):413-8. PubMed ID: 18096830
[TBL] [Abstract][Full Text] [Related]
3. Synergism of aspirin and heparin with a low-frequency non-invasive ultrasound system for augmentation of in-vitro clot lysis.
Atar S; Neuman Y; Miyamoto T; Chen M; Birnbaum Y; Luo H; Kobal S; Siegel RJ
J Thromb Thrombolysis; 2003 Jun; 15(3):165-9. PubMed ID: 14739625
[TBL] [Abstract][Full Text] [Related]
4. Arterial antithrombotic effects of aspirin, heparin, enoxaparin and clopidogrel alone, or in combination, in the rat.
Daykin HJ; Sturgeon SA; Jones C; Wright CE
Thromb Res; 2006; 118(6):755-62. PubMed ID: 16410020
[TBL] [Abstract][Full Text] [Related]
5. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
Vilahur G; Segalés E; Salas E; Badimon L
Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
[TBL] [Abstract][Full Text] [Related]
6. Intravenous magnesium in experimental stent thrombosis in swine.
Rukshin V; Azarbal B; Shah PK; Tsang VT; Shechter M; Finkelstein A; Cercek B; Kaul S
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1544-9. PubMed ID: 11557686
[TBL] [Abstract][Full Text] [Related]
7. Effect of externally applied focused acoustic energy on clot disruption in vitro.
Westermark S; Wiksell H; Elmqvist H; Hultenby K; Berglund H
Clin Sci (Lond); 1999 Jul; 97(1):67-71. PubMed ID: 10369795
[TBL] [Abstract][Full Text] [Related]
8. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
Helft G; Gilard M; Le Feuvre C; Zaman AG
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
[TBL] [Abstract][Full Text] [Related]
9. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Vilahur G; Casaní L; Badimon L
Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
[TBL] [Abstract][Full Text] [Related]
10. Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
Tohti I; Tursun M; Umar A; Turdi S; Imin H; Moore N
Thromb Res; 2006; 118(6):733-9. PubMed ID: 16469363
[TBL] [Abstract][Full Text] [Related]
11. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry.
Gupta V; Aravamuthan BR; Baskerville S; Smith SK; Gupta V; Lauer MA; Fischell TA
J Invasive Cardiol; 2004 Jun; 16(6):304-10. PubMed ID: 15155999
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry of thrombi following iliac venous stenting: a novel model of venous thrombosis.
Burches B; Karnicki K; Wysokinski W; McBane RD
Thromb Haemost; 2006 Nov; 96(5):618-22. PubMed ID: 17080219
[TBL] [Abstract][Full Text] [Related]
13. Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system.
Palmerini T; Coller BS; Cervi V; Tomasi L; Marzocchi A; Marrozzini C; Leone O; Piccioli M; Branzi A
J Am Coll Cardiol; 2004 Oct; 44(8):1570-7. PubMed ID: 15489087
[TBL] [Abstract][Full Text] [Related]
14. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
[TBL] [Abstract][Full Text] [Related]
15. There is synergism between high-intensity, low-frequency ultrasound and streptokinase but not with eptifibatide, heparin, and aspirin. Differential effects on fresh and aged blood clots. An in vitro study.
Wyshelesky A; Iakobishvili Z; Matz I; Golovchiner G; Vaturi M; Siegel RJ; Birnbaum Y
Thromb Res; 2001 Aug; 103(4):337-44. PubMed ID: 11562343
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution.
Birnbaum Y; Atar S; Luo H; Nagai T; Siegel RJ
Thromb Res; 1999 Dec; 96(6):451-8. PubMed ID: 10632468
[TBL] [Abstract][Full Text] [Related]
17. Enhanced clot dissolution in vitro by 1.8-MHz pulsed ultrasound.
Eggers J; Ossadnik S; Seidel G
Ultrasound Med Biol; 2009 Mar; 35(3):523-6. PubMed ID: 19041172
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of platelet-leukocyte aggregates and platelet activation in blood: heparin-coated coiled wire stent implantation versus balloon angioplasty in acute myocardial infarction.
Jaster M; Schwimmbeck P; Spencker S; Schultheiss HP; Rauch U
Thromb Res; 2003; 112(5-6):285-9. PubMed ID: 15041271
[TBL] [Abstract][Full Text] [Related]
19. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL
J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs.
Atar S; Luo H; Birnbaum Y; Nagai T; Siegel RJ
J Thromb Thrombolysis; 2001 May; 11(3):223-8. PubMed ID: 11577261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
